BRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

BioRestorative Therapies Insider Trading History Chart

BioRestorative Therapies Share Price & Price History

^$1.78

▼ -0.03 (-1.66%)

As of 04/1/2025 05:00 PM ET

Days: 30 | 90 | 365

BioRestorative Therapies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/27/2023	Dale Broadrick	Major Shareholder	Buy	1,000	$2.80	$2,800.00	306,073
7/25/2023	Lance Alstodt	CEO	Buy	4,200	$2.44	$10,248.00	184,418
3/31/2023	Francisco Silva	VP	Buy	747	$3.56	$2,659.32	159,690
2/22/2023	Dale Broadrick	Major Shareholder	Buy	6,000	$2.86	$17,160.00	305,073
2/1/2023	Lance Alstodt	CEO	Buy	400	$3.10	$1,240.00	187,321
1/27/2023	Lance Alstodt	CEO	Buy	200	$3.01	$602.00	186,921
1/20/2023	Lance Alstodt	CEO	Buy	200	$3.13	$626.00	186,721
1/18/2023	Lance Alstodt	CEO	Buy	400	$3.11	$1,244.00	186,521
1/9/2023	Lance Alstodt	CEO	Buy	100	$3.08	$308.00	186,121
12/23/2022	Lance Alstodt	CEO	Buy	300	$3.01	$903.00	186,021
12/7/2022	Lance Alstodt	CEO	Buy	1,800	$2.99	$5,382.00	185,721
11/21/2022	Francisco Silva	VP	Buy	943	$2.62	$2,470.66	166,046
11/18/2022	Lance Alstodt	CEO	Buy	1,000	$2.88	$2,880.00	183,921
10/11/2022	Francisco Silva	VP	Buy	806	$3.69	$2,974.14	164,378
9/23/2022	Dale Broadrick	Major Shareholder	Buy	300	$2.83	$849.00	298,873
9/22/2022	Lance Alstodt	CEO	Buy	200	$2.92	$584.00	182,921
8/29/2022	Francisco Silva	VP	Buy	2,816	$3.21	$9,039.36	163,572
8/26/2022	Francisco Silva	VP	Buy	2,600	$3.35	$8,710.00	160,756
7/12/2022	Dale Broadrick	Major Shareholder	Buy	900	$2.97	$2,673.00	298,373
7/12/2022	Lance Alstodt	CEO	Buy	700	$2.95	$2,065.00	182,721
7/6/2022	Dale Broadrick	Major Shareholder	Buy	100	$3.38	$338.00	297,473
6/30/2022	Dale Broadrick	Major Shareholder	Buy	1,900	$3.08	$5,852.00	297,373
6/30/2022	Lance Alstodt	CEO	Buy	1,100	$3.10	$3,410.00	182,021
6/21/2022	Dale Broadrick	Major Shareholder	Buy	100	$3.68	$368.00	295,473
6/17/2022	Dale Broadrick	Major Shareholder	Buy	600	$3.80	$2,280.00	295,373
6/15/2022	Dale Broadrick	Major Shareholder	Buy	1,200	$3.72	$4,464.00	292,773
6/15/2022	Lance Alstodt	CEO	Buy	700	$3.68	$2,576.00	180,321
6/15/2022	Robert Eugene Kristal	CFO	Buy	194	$3.61	$700.34	7,994
6/13/2022	Dale Broadrick	Major Shareholder	Buy	1,300	$3.92	$5,096.00	291,573
6/13/2022	Lance Alstodt	CEO	Buy	200	$3.95	$790.00	179,121
6/10/2022	Dale Broadrick	Major Shareholder	Buy	600	$4.23	$2,538.00	290,273
6/8/2022	Dale Broadrick	Major Shareholder	Buy	2,400	$4.33	$10,392.00	288,673
6/8/2022	Lance Alstodt	CEO	Buy	100	$4.28	$428.00	178,921
6/7/2022	Robert Eugene Kristal	CFO	Buy	200	$4.56	$912.00	7,800
6/6/2022	Dale Broadrick	Major Shareholder	Buy	3,000	$4.93	$14,790.00	282,673
6/2/2022	Dale Broadrick	Major Shareholder	Buy	1,000	$4.69	$4,690.00	278,473
6/1/2022	Lance Alstodt	CEO	Buy	200	$4.60	$920.00	178,821
5/26/2022	Dale Broadrick	Major Shareholder	Buy	4,950	$3.51	$17,374.50	259,303
5/26/2022	Lance Alstodt	CEO	Buy	2,700	$3.52	$9,504.00	178,621
5/2/2022	Lance Alstodt	CEO	Buy	400	$3.95	$1,580.00	175,921
4/8/2022	Robert Eugene Kristal	CFO	Buy	7,600	$5.71	$43,396.00	7,600
4/5/2022	Dale Broadrick	Major Shareholder	Buy	46,000	$5.71	$262,660.00	254,353

See Full Table

SEC Filings (Institutional Ownership Changes) for BioRestorative Therapies (OTCMKTS:BRTX)

69.38% of BioRestorative Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BioRestorative Therapies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
2/8/2023	Cambridge Investment Research Advisors Inc.	28,050	$77K	0.0%	+22.0%	0.768%
5/12/2022	Ayrton Capital LLC	77,762	$0.41M	0.5%	-31.0%	2.144%

Data available starting January 2016

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Today's Range

Now: $1.78

$1.72

$1.80

50 Day Range

MA: $1.97

$1.43

$2.49

52 Week Range

Now: $1.78

$1.03

$2.55

Volume

29,650 shs

Average Volume

393,286 shs

Market Capitalization

$12.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

64.37

Who are the company insiders with the largest holdings of BioRestorative Therapies?: BioRestorative Therapies' top insider investors include:
Dale Broadrick (Major Shareholder)
Lance Alstodt (CEO)
Learn More about top insider investors at BioRestorative Therapies.